XM does not provide services to residents of the United States of America.
L
L

Lancashire

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK's FTSE 100 ends higher supported by commodity-linked stocks

UPDATE 1-UK's FTSE 100 ends higher supported by commodity-linked stocks For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window FTSE 100 up 0.5%, FTSE 250 adds 0.3% BT Group jumps after India's Bharti to buyout top shareholder UK July CPI due Wednesday, June wages data due Tuesday Updated at 1603 GMT By Purvi Agarwal and Roshan Abraham Aug 12 (Reuters) - London stocks kicked off the week on a positive note on Monday, supported by resources-linke
B
E
L
U

European insurers enjoy big profits after premium hikes

WRAPUP 1-European insurers enjoy big profits after premium hikes By Carolyn Cohn, Tom Sims and Yadarisa Shabong LONDON, Aug 8 (Reuters) - Several European insurers recorded bumper first-half profits on Thursday, as customers burnt by a pandemic, war and a pick-up in natural catastrophes in recent years continue to face higher premiums on policies.
B
L
A
Z
U

Lancashire Holdings Posts HY Profit After Tax Of $200.8 Mln

BRIEF-Lancashire Holdings Posts HY Profit After Tax Of $200.8 Mln Aug 8 (Reuters) - Lancashire Holdings Ltd LRE.L : LANCASHIRE HOLDINGS: HY PROFIT AFTER TAX OF $200.8 MILLION LANCASHIRE HOLDINGS: INTERIM DIVIDEND OF 7.5 CENTS PER COMMON SHARE LANCASHIRE HOLDINGS: ON TRACK TO DELIVER ON OUR FULL YEAR GUIDANCE FOR AN AVERAGE LOSS YEAR UNDISCOUNTED CO
L

UK Stocks-Factors to watch on August 8

UK Stocks-Factors to watch on August 8 Aug 8 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Thursday, with futures FFIc1 down 0.5%. * GSK: The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial when jurors could not agree about whether pharmaceutical company Boehringer Ingelheim was responsible for an Illinois man's cancer.
A
A
B
B
B
D
F
G
H
I
I
L
P
P
P
R
S
S
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.